Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Obi

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
The American Journal of Managed Care|June 26, 2018
Placement of selected new FDA-approved drugs in Medicare Part D formularies, 2009-2013Bruce C Stuart, Sarah E Tom, Michelle Choi, et al.
Nigerian Journal of Medicine : Journal of the National Association of Resident Doctors of Nigeria|January 11, 2013
Coinfection with hepatitis B and C viruses among HIV positive pregnant women in Enugu south east, NigeriaT C Okeke, S N Obi, O A Okezie, et al.
Journal of Cardiac Failure|August 21, 2025
Characterizing real-world use of vericiguat in the USAlejandro Victores, Lori D Bash, Boshu Ru, et al.
Digital Health|November 3, 2025
Integration of digital health into pharmacy education in Nigeria: Challenges and recommendations for national adoptionOluwaseyi M Egbewande, Salim S Haladu, Godspower Akpovwobaa, et al.
Infectious Diseases and Therapy|December 2, 2022
Correction to: Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital SystemLauren F McDaniel, Melissa N White, Engels N Obi, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 9, 2014
Collection of vaccination data in the German National Cohort : Findings of a feasibility study in three study centersA Schultze, M K Akmatov, S Castell, et al.
Infectious Diseases and Therapy|July 19, 2022
Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital SystemLauren F McDaniel, Melissa N White, Engels N Obi, et al.
Anaerobe|August 8, 2022
Appropriate cleaning reduces potential risk of spore transmission from patients with Clostridioides difficile infection treated in outpatient infusion centersClaudia P Schroeder, Richard L Hengel, Ramesh V Nathan, et al.
Journal of Global Antimicrobial Resistance|January 26, 2025
Unveiling results and insights from multinational, multicenter Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA)Alex Soriano, David L Paterson, Florian Thalhammer, et al.
Diagnostic Microbiology and Infectious Disease|February 16, 2025
A real-world investigation into prescribing patterns and effectiveness of ceftolozane/tazobactam among critically ill patients from SPECTRAAlex Soriano, David L Paterson, Florian Thalhalmmer, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
The American Journal of Managed Care|June 26, 2018
Placement of selected new FDA-approved drugs in Medicare Part D formularies, 2009-2013Bruce C Stuart, Sarah E Tom, Michelle Choi, et al.
Nigerian Journal of Medicine : Journal of the National Association of Resident Doctors of Nigeria|January 11, 2013
Coinfection with hepatitis B and C viruses among HIV positive pregnant women in Enugu south east, NigeriaT C Okeke, S N Obi, O A Okezie, et al.
Journal of Cardiac Failure|August 21, 2025
Characterizing real-world use of vericiguat in the USAlejandro Victores, Lori D Bash, Boshu Ru, et al.
Digital Health|November 3, 2025
Integration of digital health into pharmacy education in Nigeria: Challenges and recommendations for national adoptionOluwaseyi M Egbewande, Salim S Haladu, Godspower Akpovwobaa, et al.
Infectious Diseases and Therapy|December 2, 2022
Correction to: Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital SystemLauren F McDaniel, Melissa N White, Engels N Obi, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 9, 2014
Collection of vaccination data in the German National Cohort : Findings of a feasibility study in three study centersA Schultze, M K Akmatov, S Castell, et al.
Infectious Diseases and Therapy|July 19, 2022
Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital SystemLauren F McDaniel, Melissa N White, Engels N Obi, et al.
Anaerobe|August 8, 2022
Appropriate cleaning reduces potential risk of spore transmission from patients with Clostridioides difficile infection treated in outpatient infusion centersClaudia P Schroeder, Richard L Hengel, Ramesh V Nathan, et al.
Journal of Global Antimicrobial Resistance|January 26, 2025
Unveiling results and insights from multinational, multicenter Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA)Alex Soriano, David L Paterson, Florian Thalhammer, et al.
Diagnostic Microbiology and Infectious Disease|February 16, 2025
A real-world investigation into prescribing patterns and effectiveness of ceftolozane/tazobactam among critically ill patients from SPECTRAAlex Soriano, David L Paterson, Florian Thalhalmmer, et al.
Pageof 12